Isoten

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Isoten

Property Description
Active Ingredient Bisoprolol fumarate
Form Film-coated tablet (Oral)
Pharmacological Class Cardioselective beta1-blocker
General Purpose Provides stable cardiovascular support
Origin Synthetic compound

What is Isoten and What is it Made Of?

Isoten is a synthetic, prescription-only medication administered as an oral dosage form, specifically a film-coated tablet. The preparation contains a single active substance, Bisoprolol fumarate, a potent chemical compound designed for the long-term management of cardiovascular dynamics. Its identity as a single-ingredient drug ensures reliable and predictable pharmacological action, supporting consistent control necessary for patients in stable therapeutic regimens. Bisoprolol is a beta-blocker that functions to lower blood pressure, acting to manage cardiovascular function.


Isoten’s Classification: A Cardioselective Beta-Blocker

Isoten belongs to the pharmacological class known as a beta-adrenergic blocking agent, more commonly termed a beta-blocker. This classification is further refined by its status as a cardioselective beta1-blocker. This means the active ingredient, Bisoprolol fumarate, is highly selective for the beta1-adrenoceptors, which are predominantly situated in the heart muscle tissue. This focused affinity differentiates it from non-selective beta-blockers, allowing for a more targeted influence on cardiac function.


What is the General Purpose of Isoten?

The general purpose of Isoten is to provide stable, protective support for the cardiovascular system by modulating the heart’s response to stress. The medication's primary physiological effects are a reduction in the rate of the heartbeat (negative chronotropy) and a decrease in the force of the heart’s muscular contraction. This dual action lessens the overall workload and energy demand placed on the myocardium. This profile makes it a typical and effective choice for patients requiring stable control of cardiac output.

What side effects are possible with Isoten?

Possible Side Effects and Safety Information

The official safety information for Isoten (Bisoprolol fumarate) outlines potential adverse reactions by frequency and the body system affected, based on regulatory documentation. Many of the adverse effects are categorized as transient, often appearing at the start of treatment before resolving within the first two weeks.

Frequency-Classified Adverse Reactions

Adverse reactions are formally categorized from Common to Very Rare in regulatory documents. Common reactions, affecting up to 1 in 10 individuals, typically include fatigue, dizziness, headache, and mild gastrointestinal disturbances such as nausea, vomiting, or diarrhea. Less frequent reactions, categorized as Uncommon or Rare, may involve sleep disorders, depression, muscle weakness, or muscular cramps.

Serious Adverse Reactions and Safety Constraints

Regulatory agencies document specific serious adverse reactions, including the potential for worsening of acute heart failure or the occurrence of severe bradycardia (slowed heart rate). The medication is subject to absolute contraindications that restrict its use in patients with certain severe acute conditions, such as cardiogenic shock, marked sinus bradycardia, or severe bronchial asthma, as defined in official labeling.

Population-Specific Safety Notes

The official labeling notes that caution is warranted for patients with impaired renal or hepatic function, as this may affect the body's elimination of the medicine. In patients with diabetes, the drug may mask certain symptoms of hypoglycemia, necessitating careful monitoring. Furthermore, abrupt cessation of therapy in individuals with underlying coronary artery disease has been documented to potentially lead to the exacerbation of angina.

Overdose and Emergency Response

Overdose and When to Seek Help

This information is strictly based on the official overdose and emergency instructions documented by government regulatory authorities for Bisoprolol fumarate (Isoten).


Documented Manifestations of Overdose

Overdose with this medication is associated with specific clinical signs that reflect its action on the cardiovascular system. The primary manifestations formally documented in regulatory labeling include:

  • Bradycardia: An abnormally slow heart rate.
  • Hypotension: Abnormally low blood pressure.

Required Emergency Actions and Management

In the event of a suspected overdose, it is essential to act immediately, as mandated by regulatory documents:

  1. Seek Immediate Medical Attention: Anyone suspected of an Isoten overdose must seek immediate medical attention or contact emergency services.
  2. Stop Therapy: The Bisoprolol fumarate therapy should be stopped at once.

Official management protocols require providing supportive and symptomatic treatment. In reported cases, sympathomimetic agents were administered successfully to counteract the effects. Regulatory information also notes that the active substance is generally considered not dialyzable.

There are no explicit population-specific overdose considerations (e.g., for pediatric or hepatic impairment) documented uniquely within the official Bisoprolol overdose sections.

Therapeutic Uses of Isoten

What Isoten treats: main uses and benefits

Isoten is commonly used to help with conditions characterized by periods of heightened symptoms related to inflammatory or irritative states. The treatment is relevant for managing symptoms associated with acute or disruptive episodes.

The medicine's use assists with maintaining functional stability by helping address symptom clusters that create noticeable physiological strain. It is often used during phases when symptoms become more noticeable and may be part of symptomatic management when supportive relief is needed. This therapeutic approach is generally applied in addressing symptoms of increased neurological or muscular activity, symptoms that interfere with daily functioning, and symptoms related to inflammatory or irritative states. The treatment is generally used across conditions presenting with acute episodes.

This focus on short-term symptomatic assistance supports patients during episodes of heightened discomfort by easing the overall symptom burden. It is considered relevant when supportive symptom management is appropriate. The treatment is relevant when symptoms become temporarily overwhelming, contributing to improved comfort during periods of heightened symptoms.

Quick Fact: Relief for symptoms related to inflammatory or irritative states

Eligibility and Restrictions for Use

The eligibility for using Isoten (Bisoprolol fumarate) is strictly defined by regulatory authorities and is generally limited to adult patients (18 years and older).


Populations for Whom Use is Contraindicated

Isoten is contraindicated, meaning it must not be used, in patients with conditions that include acute heart failure or decompensation, cardiogenic shock, second or third-degree AV block (without a pacemaker), severe symptomatic bradycardia, sick sinus syndrome, and severe bronchial asthma or Chronic Obstructive Pulmonary Disease (COPD). Use is also prohibited if there is a known hypersensitivity to the drug.


Populations Requiring Conditional Use

The medicine is not recommended for the pediatric population (under 18 years) as its safety and effectiveness have not been established. Patients with severe renal or hepatic impairment have an official maximum dose restriction documented in the label for certain indications. Caution is specifically advised for patients with diabetes mellitus (due to potential masking of hypoglycemia symptoms) and other bronchospastic diseases. Use during pregnancy is advised only if clearly needed, and it is generally not recommended during lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Isoten's official interaction profile is defined by its potential to interact with other substances through both additive cardiovascular effects and changes in its metabolism, based on regulatory documentation.

Pharmacodynamic Reinforcement

Co-administration with other medicines that slow the heart rate or depress heart function may result in severe additive effects. Combinations with other systemic beta-blocking agents are restricted. The use of Isoten with Calcium Antagonists of the Verapamil and Diltiazem types is highly restricted due to the potential for compounded negative influence on myocardial contractility and atrioventricular (AV) conduction.

Other substances that may increase the risk of bradycardia and depressed AV conduction include Antiarrhythmic Agents (e.g., Amiodarone, Digoxin). Centrally-acting Antihypertensives (e.g., Clonidine) may also worsen cardiac function; if therapy is discontinued, Isoten must be stopped for several days before the withdrawal of Clonidine. Nonsteroidal Anti-inflammatory Drugs (NSAIDs) may decrease Isoten’s blood pressure-lowering activity through antagonism.

Pharmacokinetic and Substance Interactions

The concurrent use of the antibiotic Rifampin increases the metabolic clearance of Isoten, resulting in a documented shortened elimination half-life. Regarding consumption, Isoten absorption is unaffected by food intake, but alcohol may enhance the overall blood pressure-lowering effects. Population-specific cautions exist, as the risk of increased drug exposure and related adverse effects is heightened in patients with significant renal or hepatic dysfunction.

Mechanism of Action

How Isoten Works

β₁-Receptor Blockade and Cardiac Dampening

Isoten (Bisoprolol) acts as a competitive antagonist primarily targeting the β₁-adrenergic receptors located on cardiac myocytes and the heart's conduction system. This interaction prevents the binding of endogenous ligands, the catecholamines (norepinephrine and epinephrine). By blocking this key molecular target, the drug modulates the sympathetic nervous system's signaling influence on cardiac function. This action results in a reduction in the electrical firing rate (negative chronotropy) and the pumping force (negative inotropy) of the heart muscle.


Intracellular Signal Modulation and Systemic Effect

Antagonism initiates an intracellular cascade by suppressing the Gₛ protein and inhibiting adenylyl cyclase. This reduces the formation of cAMP, decreasing the influx of calcium ions into the cardiac cells. This molecular modification reduces the kinetic energy demand on the heart and lowers the overall myocardial oxygen consumption. Additionally, blockade of β₁-receptors in the kidneys' juxtaglomerular cells limits the release of renin, resulting in a reduction of downstream vasoconstrictive signaling.

Dosage and Administration Information

Isoten is a prescription medication administered orally as a film-coated tablet. The medicine is intended for long-term use and is taken once daily (qDay), preferably in the morning. The tablet may be consumed either with or without food, as absorption is not significantly affected by meals. The tablet is swallowed whole with water and is not to be crushed, chewed, or divided.


Dosing Regimens

Standard dosing regimens vary based on the specific clinical application.

Usage Scenario Starting Dose Maintenance Dose (Max Daily)
Hypertension/Angina Typically 5 mg once daily. 5 mg to 10 mg (20 mg maximum)
Stable Heart Failure 1.25 mg once daily. Gradually titrated up to 10 mg maximum

For the management of stable chronic heart failure, administration begins with a low dose, requiring a gradual, stepwise titration (dose doubling) over weekly intervals. This titration is performed under professional supervision to ensure the body adjusts to the therapy.

Administration Constraints and Cessation Protocol

The maximum recommended daily dose of Isoten should not exceed 10 mg for patients with severe renal or hepatic impairment. Furthermore, treatment is defined as long-term therapy. Abrupt cessation is generally avoided; instead, therapy is discontinued through a slow, stepwise tapering process over a period of one to two weeks. Safety and efficacy for use in the pediatric population have not been established.

Recent Clinical Evidence

Research evidence / Overview of Studies for Isoten (Bisoprolol Fumarate)


Evidence from Controlled Trials in Chronic Heart Failure

Isoten (Bisoprolol fumarate) was studied for use in adults with Chronic Heart Failure (CHF), particularly those whose heart function was observed to be reduced. The research involved large, randomized, controlled trials (RCTs), which are designed to minimize bias, to examine the research question regarding the drug when patients were already receiving other standard therapies.

The outcomes monitored in these key trials included metrics such as all-cause mortality and cardiovascular mortality, and the frequency of hospitalizations. Researchers also tracked changes in physiological strain and measures of heart function (LVEF and heart rate). Findings describe patterns observed in the study groups related to these outcomes, reporting changes recorded during the observed periods compared to control groups.

Evidence from Clinical Trials for High Blood Pressure

Research was evaluated in adults with mild to moderate high blood pressure (hypertension). These studies primarily involved controlled trials designed to monitor short-term or intermediate physiological responses. The core outcomes evaluated were the magnitude of reduction in systolic and diastolic blood pressure and the change in heart rate.

The trials reported that blood pressure and heart rate measurements were recorded during the study period, with data showing patterns related to the administration of the study drug. The research provides context for data patterns related to fundamental cardiovascular markers.

Evidence in Secondary Prevention Post-Heart Events

Research was monitored in patients who had experienced a Myocardial Infarction (MI), or heart attack, especially those with some degree of persistent heart muscle dysfunction after the event. Studies focusing on this population were designed to monitor the rates of morbidity and mortality and track measures such as Heart Rate (HR) and Left Ventricular Ejection Fraction (LVEF) in the post-MI setting.

Studies described the data concerning the rate of survival and the frequency of subsequent cardiac events recorded in the post-MI cohorts. The evidence is one component of the broader evidence landscape related to the secondary prevention setting.

What is Still Uncertain About Isoten Studies

Despite the existence of clinical trials, certain limitations are important for context. For several key patient groups, such as those with certain comorbidities or very advanced chronic kidney disease, the sample sizes were modest in the primary trials, meaning certainty remains low for findings for these specific groups. The overall research provides context, but study results reflect the specific conditions under which they were conducted, not personal outcomes.

Frequently Asked Questions (FAQ)

Common questions about Isoten (FAQ)

Q: What should I do if I forget to use Isoten?

If a regular dose is missed, official patient information describes an action of taking it as soon as the lapse is remembered on the same day. However, if the following day has already started, the protocol described is to skip the missed dose entirely. It is stated in regulatory guidance that a double dose should never be taken to compensate for a forgotten one.

Q: Is it normal to feel worse before feeling better when starting Isoten?

Official safety information notes that many reported adverse effects, such as fatigue, headache, or dizziness, are often described as transient (temporary). These effects frequently appear when starting treatment but may resolve on their own within the first two weeks as the body adjusts to the medication.

Q: Is Isoten available over the counter, or is it prescription only?

Isoten is defined in regulatory documents as a prescription-only medication. Its status as a prescription-only medication means it is dispensed under the supervision of a licensed healthcare provider and is not available for general purchase over the counter.

Q: What are the most common reasons people stop using Isoten?

While the overall reasons for discontinuation are not summarized in a single place, the official safety data lists common or serious adverse reactions that might lead to ending treatment. These include common transient effects like fatigue and dizziness, as well as more serious potential events such as a severe slowing of the heart rate (bradycardia) or a worsening of heart failure.

Q: What happens if I accidentally take more Isoten than instructed?

Official warnings note that taking more Isoten than prescribed may lead to serious health concerns, such as excessively slow heart rate, low blood pressure, difficulty breathing, or dizziness. Regulatory documents state that an overdose requires immediate medical attention.

Q: Does Isoten make you more sensitive to the sun?

Photosensitivity (an increased sensitivity of the skin to sunlight) has been noted as a potential risk associated with this drug class. Safety precautions for sun exposure, such as wearing protective clothing and sunscreen, are often recommended in the context of this drug class.

Q: Are there different strengths or forms of Isoten?

Yes, official labeling confirms that Isoten is typically manufactured as a film-coated tablet in multiple strengths. The available strengths may include 5 mg and 10 mg for the single-ingredient product.

Q: Is Isoten known to be addictive?

Isoten is not classified as a controlled substance and is not described as having an addictive potential. However, treatment should not be stopped suddenly because abrupt cessation requires a gradual tapering protocol over a period of one to two weeks, as defined in regulatory documents.

Q: How soon after stopping Isoten can I become pregnant?

Official documents describe the body's rate of elimination (half-life) for the drug, which is typically 9–12 hours. Because this drug class has been associated with fetal risk, consultation with a healthcare provider is necessary for individuals planning or attempting to become pregnant to fully assess the risks and benefits in this specific context.

Q: Does Isoten cause weight gain or loss?

Official safety documents include weight changes on the list of potential adverse reactions. These effects are typically categorized among common adverse reactions or those related to broader metabolic changes.

Q: What is the required waiting period after finishing Isoten before starting certain procedures?

Official warnings note that chronic beta-blocker therapy can affect the heart's response to stress signals and may affect the risks associated with general anesthesia. Regulatory documents specify that any change or discontinuation prior to major surgery or certain medical procedures requires discussion with the supervising healthcare provider.

Q: Does Isoten affect vision?

Official safety documents list rare adverse reactions that can affect the eyes. These include visual disturbances, conjunctivitis (red eye), and reduced tear flow, which is particularly relevant for individuals who wear contact lenses.

Q: Is there a generic version of Isoten available?

Yes, regulatory and public health databases confirm that the active ingredient in Isoten, Bisoprolol fumarate, is widely available in generic formulations.

Q: What is the maximum duration someone can typically use Isoten for?

Official documentation defines the treatment for chronic cardiovascular conditions as long-term therapy, and sometimes for the rest of one's life. No formal maximum duration is specified in regulatory labels.

Q: Can I use alcohol while taking Isoten?

Official interaction warnings state that co-administration with alcohol may result in an additive effect in lowering blood pressure. This effect can increase the potential for symptoms such as dizziness, light-headedness, or fainting.

Q: What are the signs that Isoten is working properly?

The intended physiological effects described in clinical documents include a desirable reduction in resting heart rate and a fall in systolic and diastolic blood pressure. These effects typically begin to be observed within one week of starting treatment.

Q: Why is Isoten only prescribed in certain circumstances?

Isoten is only prescribed in specific circumstances because its use is strictly defined by regulatory authorities based on clinical trial evidence. It is approved for conditions like hypertension and stable chronic heart failure, and its use is prohibited (contraindicated) in patients with severe acute heart conditions, which limits who can receive the prescription.

Q: Can Isoten be taken with vitamins or mineral supplements?

Official interaction data suggests that certain multivitamin and mineral supplements may potentially decrease the effects of Isoten. A separation of administration times for these supplements and the medication, often by at least two hours, is suggested to mitigate potential interaction.

Q: How long does it typically take to see any effects from Isoten?

Initial changes in blood pressure may be noted within one week of starting treatment. However, the full blood pressure-lowering effect described in clinical studies may take between two to six weeks to fully materialize.

Q: Is Isoten considered safe for long-term use?

Official documentation defines the therapy as long-term treatment for chronic conditions. As with any chronic medication, long-term use requires careful monitoring for potential adverse reactions and periodic health evaluation by a healthcare provider.

Q: Can Isoten cause changes in mood or sleep?

Official safety documents list both sleep disorders and depression as uncommon adverse reactions. Furthermore, rare reactions noted in official reports include nightmares and hallucinations.

Q: Can I take Isoten if I am trying to get pregnant?

Official information states that use during pregnancy is advised only if clearly needed due to observed risks in some studies. Consultation with a healthcare provider is necessary for individuals planning or attempting to become pregnant to fully assess the risks and benefits in this specific context.

Q: Are there any specific foods or drinks to avoid while using Isoten?

Official pharmacokinetic data confirms that the drug's absorption is not affected by food. However, co-administration with alcohol may enhance the blood pressure-lowering effects.

Q: Does Isoten affect kidney function?

Official documents note that caution is warranted in patients who already have impaired kidney function, as the drug is partially cleared by the kidneys. Renal-related adverse changes have also been noted in postmarketing reports, which is a factor considered during patient monitoring.

Q: Can Isoten be used by people with a history of depression?

Official safety information lists depression as an uncommon adverse reaction associated with the medication. While a history of depression is not an absolute contraindication, the potential for mood disturbance as a side effect is noted for caution.

Q: Are the side effects of Isoten temporary or permanent?

Official safety information categorizes many common adverse effects, such as headache and fatigue, as transient (temporary), often resolving within the first two weeks of treatment. However, some long-term or serious adverse effects are also documented in regulatory reports.

Q: Does Isoten affect cholesterol levels?

Official safety data includes metabolic effects such as cholesterol changes and an increase in triglycerides as potential adverse reactions, categorized as rare events.

Q: Can Isoten be taken on an empty stomach?

Yes, official pharmacokinetic data confirms that the drug's absorption and effectiveness are not affected by the presence of food. Therefore, it can be taken with or without food.

How should Isoten be stored and disposed of?

How to Store and Dispose of Isoten?

Isoten (isotretinoin) capsules must be stored in the original container, tightly closed, at room temperature and protected from excessive heat and moisture (avoid storing in a bathroom). Do not allow the medication to freeze. It is essential to keep Isoten out of the reach of children to prevent accidental ingestion, which can cause serious harm.

Due to the significant risks associated with this medication, particularly birth defects, any unused or expired capsules must be disposed of carefully. Do not throw Isoten into household trash or flush it down a toilet or sink. The preferred and safest method for disposal is to return the unused medication to a pharmacy or healthcare provider under a specialized drug take-back program. If no take-back program is available, consult your pharmacist or healthcare professional for specific, authorized disposal instructions in your area.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Isoten found in:

A-Z Index: